Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 6, 2016, Pages 1742-1750.e4

  Zhao, Zuo Tao ^a,d   Ji, Chun Mei ^b   Yu, Wen Jun ^c   Meng, Ling ^b   Hawro, Tomasz ^d   Wei, Ji Fu ^b   Maurer, Marcus ^a,d  

^a PEKING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Jiangsu Province Official Hospital   (China)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

adverse event; CSU; meta analysis; Omalizumab; weekly itch score; weekly wheal score

Indexed keywords

OMALIZUMAB; PLACEBO; ANTIALLERGIC AGENT;

ARTICLE; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOPHARYNGITIS; RISK ASSESSMENT; SKIN DISEASE; SUBCUTANEOUS DISORDER; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; CHRONIC DISEASE; ODDS RATIO; PUBLISHING; TREATMENT OUTCOME; URTICARIA;

ANTI-ALLERGIC AGENTS; CHRONIC DISEASE; HUMANS; ODDS RATIO; OMALIZUMAB; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; URTICARIA;

EID: 84962129031     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.12.1342     Document Type: Article

References (28)

1. M. Maurer, K. Weller, C. Bindslev-Jensen, A. Gimenez-Arnau, P.J. Bousquet, J. Bousquet, and et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report Allergy 66 2011 317 330
2. R.M. Ruggeri, S. Imbesi, S. Saitta, A. Campenni, S. Cannavo, F. Trimarchi, and et al. Chronic idiopathic urticaria and Graves' disease J Endocrinol Invest 36 2013 531 536
3. T. Zuberbier, W. Aberer, R. Asero, C. Bindslev-Jensen, Z. Brzoza, G.W. Canonica, and et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update Allergy 69 2014 868 887
4. I. Koti, K. Weller, M. Makris, E. Tiligada, T. Psaltopoulou, C. Papageorgiou, and et al. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria Dermatology 226 2013 371 379
5. R. Asero, E. Pinter, A.M. Marra, A. Tedeschi, M. Cugno, and A.V. Marzano Current challenges and controversies in the management of chronic spontaneous urticaria Expert Rev Clin Immunol 11 2015 1073 1082
6. E. Toubi, A. Kessel, N. Avshovich, E. Bamberger, E. Sabo, D. Nusem, and et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients Allergy 59 2004 869 873
7. M. Maurer, M.K. Church, M. Goncalo, G. Sussman, and M. Sanchez-Borges Management and treatment of chronic urticaria (CU) J Eur Acad Dermatol Venereol 29 suppl 3 2015 16 32
8. J.D. Wright, H.M. Chu, C.H. Huang, C. Ma, T. Wen Chang, and C. Lim Structural and physical basis for anti-IgE therapy Sci Rep 5 2015 11581
9. L.A. Beck, G.V. Marcotte, D. MacGlashan, A. Togias, and S. Saini Omalizumab-induced reductions in mast cell Fce psilon RI expression and function J Allergy Clin Immunol 114 2004 527 530
10. S.L. Spector, and R.A. Tan Effect of omalizumab on patients with chronic urticaria Ann Allergy Asthma Immunol 99 2007 190 193
11. C. Vestergaard, and M. Deleuran Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab Acta Derm Venereol 90 2010 443 444
12. M. Magerl, P. Staubach, S. Altrichter, E. Ardelean, K. Krause, M. Metz, and et al. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab J Allergy Clin Immunol 126 2010 665 666
13. P.M. Silva, A.C. Costa, A. Mendes, and M.P. Barbosa Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria Allergol Immunopathol (Madr) 43 2015 168 173
14. R.K. Viswanathan, M.H. Moss, and S.K. Mathur Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria Allergy Asthma Proc 34 2013 446 452
15. M. Armengot-Carbo, M. Velasco-Pastor, B. Rodrigo-Nicolas, V. Pont-Sanjuan, E. Quecedo-Estebanez, and E. Gimeno-Carpio Omalizumab in chronic urticaria: a retrospective series of 15 cases Dermatol Ther 26 2013 257 259
16. A.P. Kaplan, K. Joseph, R.J. Maykut, G.P. Geba, and R.K. Zeldin Treatment of chronic autoimmune urticaria with omalizumab J Allergy Clin Immunol 122 2008 569 573
17. M. Maurer, S. Altrichter, T. Bieber, T. Biedermann, M. Brautigam, S. Seyfried, and et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase J Allergy Clin Immunol 128 2011 202 209.e5
18. S. Saini, K.E. Rosen, H.J. Hsieh, D.A. Wong, E. Conner, A. Kaplan, and et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria J Allergy Clin Immunol 128 2011 567 573.e1
19. M. Maurer, K. Rosen, H.J. Hsieh, S. Saini, C. Grattan, A. Gimenez-Arnau, and et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria N Engl J Med 368 2013 924 935
20. A. Kaplan, D. Ledford, M. Ashby, J. Canvin, J.L. Zazzali, E. Conner, and et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy J Allergy Clin Immunol 132 2013 101 109
21. S.S. Saini, C. Bindslev-Jensen, M. Maurer, J.J. Grob, E. Bulbul Baskan, M.S. Bradley, and et al. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study J Invest Dermatol 135 2015 925
22. M.C. Urgert, M.T. van den Elzen, A.C. Knulst, Z. Fedorowicz, and E.J. van Zuuren Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment Br J Dermatol 173 2015 404 415
23. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
24. L. Irwig, P. Macaskill, G. Berry, and P. Glasziou Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased BMJ 316 1998 470 author reply 471
25. A.E. Stuck, L.Z. Rubenstein, and D. Wieland Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity BMJ 316 1998 469 author reply 470-1
26. J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, and et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
27. P. Staubach, M. Metz, N. Chapman-Rothe, C. Sieder, M. Bräutigam, J. Canvin, and et al. Effect of omalizumab on angioedema in H1-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial Allergy 2016 Mar 24 [E-pub ahead of print]
28. M. Metz, P. Staubach, A. Bauer, R. Brehler, J. Gericke, J. Ashton-Chess, and et al. Omalizumab normalizes levels of high affinity immunoglobulin E receptor-positive skin mast cells in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study J Invest Dermatol 134 2014 S30 S38